Home-administered biologics for RA more common with Medicare Part D subsidiesMarch 25, 2015Rheumatoid ArthritisBusiness of Medicine
Value-based medicine gets boost from launch of information-sharing networkMarch 25, 2015Business of Medicine
Future physician shortages could be smaller than originally forecastMarch 24, 2015Business of Medicine
Study addresses outcomes of nonsevere ANCA-associated vasculitis relapses for first timeMarch 23, 2015Lupus & Connective Tissue Diseases
VIDEO: Ask vitiligo patients about autoimmune symptomsMarch 23, 2015Lupus & Connective Tissue Diseases
Methotrexate and biologics linked to higher zoster risk in psoriasisMarch 22, 2015Psoriatic ArthritisSpondyloarthropathies
Secukinumab beat ustekinumab for psoriasis, with difference by week fourMarch 21, 2015SpondyloarthropathiesPsoriatic Arthritis
Brodalumab achieved primary endpoints for moderate to severe psoriasis at 52 weeksMarch 21, 2015SpondyloarthropathiesPsoriatic Arthritis
